Yoshie Kunihiro 1 , Nobuyuki Tanaka 2 , Tsuneo Matsumoto 3 , Norihide Yamamoto 4 , Naofumi Matsunaga 2 Show Affiliations »
Abstract
BACKGROUND: The combination of high-resolution computed tomography (HRCT) findings and serum markers would be of great value in diagnosing cytomegalovirus pneumonia (CMVP) and pneumocystis pneumonia (PCP) considering low invasiveness. PURPOSE: To compare the HRCT findings of CMVP and PCP and to evaluate the differences in HRCT findings between patients diagnosed based on pathologic evidence and serum markers. MATERIAL AND METHODS: Two radiologists retrospectively evaluated the HRCT findings of 21 patients with CMVP and 70 patients with PCP. Eight patients with CMVP and 32 patients with PCP were diagnosed based on pathologic evidence ("Path" group), while 13 patients with CMVP and 38 patients with PCP were diagnosed based on serum markers (CMV antigenemia, β-D-glucan) ("Serum-Marker" group). A total of 19 CT morphological criteria were evaluated, and the significance of the differences between the two diseases and between the "Path" and "Serum-Marker" groups with respect to each disease was calculated. RESULTS: The presence of small nodules, the tree-in-bud pattern, and the halo sign was found more frequently in the CMVP group. Extensive ground-glass attenuation (GGA), a mosaic pattern, and a diffuse distribution were observed more frequently in the PCP group. There were significant differences between the "Path" and "Serum-Marker" groups in average extent of consolidation and distribution of consolidation in PCP, and the distribution of GGA in CMVP, respectively. CONCLUSION: The combined use of HRCT findings and serum markers is useful for the diagnosis of CMVP and PCP in non-AIDS patients. The typical HRCT findings for the differential diagnosis included extensive GGA with mosaic pattern in PCP and nodules, nodules with or without the tree-in-bud pattern, and the halo sign in CMVP. © The Foundation Acta Radiologica 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
BACKGROUND: The combination of high-resolution computed tomography (HRCT) findings and serum markers would be of great value in diagnosing cytomegalovirus pneumonia (CMVP) and pneumocystis pneumonia (PCP ) considering low invasiveness. PURPOSE: To compare the HRCT findings of CMVP and PCP and to evaluate the differences in HRCT findings between patients diagnosed based on pathologic evidence and serum markers. MATERIAL AND METHODS: Two radiologists retrospectively evaluated the HRCT findings of 21 patients with CMVP and 70 patients with PCP . Eight patients with CMVP and 32 patients with PCP were diagnosed based on pathologic evidence ("Path" group), while 13 patients with CMVP and 38 patients with PCP were diagnosed based on serum markers (CMV antigenemia, β-D-glucan) ("Serum-Marker" group). A total of 19 CT morphological criteria were evaluated, and the significance of the differences between the two diseases and between the "Path" and "Serum-Marker" groups with respect to each disease was calculated. RESULTS: The presence of small nodules, the tree-in-bud pattern, and the halo sign was found more frequently in the CMVP group. Extensive ground-glass attenuation (GGA), a mosaic pattern, and a diffuse distribution were observed more frequently in the PCP group. There were significant differences between the "Path" and "Serum-Marker" groups in average extent of consolidation and distribution of consolidation in PCP , and the distribution of GGA in CMVP, respectively. CONCLUSION: The combined use of HRCT findings and serum markers is useful for the diagnosis of CMVP and PCP in non-AIDS patients . The typical HRCT findings for the differential diagnosis included extensive GGA with mosaic pattern in PCP and nodules, nodules with or without the tree-in-bud pattern, and the halo sign in CMVP. © The Foundation Acta Radiologica 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Entities: Chemical
Disease
Species
Keywords:
Cytomegalovirus; HRCT; antigenemia; pneumocystis pneumonia; β-D-glucan
Mesh： See more »
Substances： See more »
Year: 2014
PMID： 25031277 DOI： 10.1177/0284185114539320
Source DB: PubMed Journal: Acta Radiol ISSN： 0284-1851 Impact factor: 1.990